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Abstract 
Background: Pediatric tuberculous meningitis is a highly morbid, often fatal disease. Its prompt diagnosis and treat-
ment saves lives, in fact delays in the initiation of therapy have been associated with high mortality rates.
Case presentation: This is a case of an Italian child who was diagnosed with tuberculous meningitis after a history 
of a month of headache, fatigue and weight loss. Cerebrospinal fluid analysis revealed a lymphocytic pleocytosis with 
predominance and decreased glucose concentration. Microscopy and conventional diagnostic tests to identify Myco-
bacterium tuberculosis were negative, while a non classical method based on intracellular cytokine flow cytometry 
response of CD4 cells in cerebral spinal fluid helped us to address the diagnosis, that was subsequently confirmed by 
a nested polymerase chain reaction amplifying a 123 base pair fragment of the M. tuberculosis DNA.
Conclusions: We diagnosed tuberculous meningitis at an early stage through an innovative immunological 
approach, supported by a nested polymerase chain reaction for detection of M. tuberculosis DNA. An early diagnosis is 
required in order to promptly initiate a therapy and to increase the patient’s survival.
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Background
Tuberculous meningitis (TBM) represents roughly 1% 
of all cases of TB and it is associated with high mortal-
ity and residual neurologic sequelae, even with adequate 
treatment. In endemic countries the highest incidence 
of TBM is reported in children aged 2–4  years [1]. 
Early diagnosis is notoriously difficult and often delayed 
and it has long been recognized as the single most 
important factor determining outcome [2]. In fact the 
microbiological diagnosis of TBM is difficult due to the 
paucibacillary nature of the cerebrospinal fluid (CSF) 
in which the microscopy for acid-fast bacilli (AFB) and 
culture for Mycobacterium (M.) tuberculosis have a low 
sensitivity [1, 3, 4]. Also commercial nucleic acid amplifi-
cation tests (NAATs) showed a low sensitivity and speci-
ficity compared to culture for the diagnosis of TBM [5]. 
An additional test is the Adenosine deaminase (ADA) 
measurements in CSF [6], even if the specificity is low 
and the cut-off level has not been determined [7].
We present a case study of an Italian child with TBM 
who was hospitalized in the Pediatric Infectious dis-
eases department of Umberto I° Hospital in Rome, and in 
whom the early diagnosis, based on immunological flow 
Open Access
BMC Research Notes
*Correspondence:  serena.vita@uniroma1.it 
1 Department of Public Health and Infectious Diseases, Sapienza 
University, 00185 Rome, Italy
Full list of author information is available at the end of the article
Page 2 of 8Vita et al. BMC Res Notes  (2017) 10:123 
cytometry test and molecular assay, allowed us to start 
an early treatment, fundamental requirement to increase 
patient’s survival.
Case report
A 9-year-old Italian girl developed headache, fatigue and 
weight loss of about 6 kg 1 month prior the admission to 
our hospital. One week before admission, because of the 
occurrence of dizziness and vomiting, she was hospital-
ized to the Neurology Department of another hospital 
in Rome, where the computed tomography (CT) scan 
of head and audiovestibular exams were normal. The 
patient was discharged with a diagnosis of “Symptomatic 
paroxysmal vertigo, migraine without aura and acute gas-
troenteritis”. Few days after the discharge, she reported 
history of sleepiness, persistence of migraine and fever. 
Thereafter, she was admitted to the Pediatric Emergency 
Department of our hospital where she had normal blood 
tests and a normal brain magnetic resonance imaging 
(MRI). The MRI is shown in Fig.  1a. A normal ocular 
fundoscopy was performed due to onset of double vision 
and she was transferred to the Department of Neuropsy-
chiatry where she underwent electroencephalogram 
(EEG) characterized by slow focal abnormalities. Dur-
ing the hospitalization, the patient experienced increased 
sleepiness and showed facial nerve palsy with a mouth 
deviation to the right side for which she was subjected 
to a lumbar puncture (LP) that showed a clear CSF with 
a white cell count (WBC) of 372/µL, a lymphocyte per-
centage of 90%, a protein level of 1.317 mg/dL, a glucose 
level of 13 mg/dL. Examination of Gram, Ziehl-Neelsen 
stain and soluble antigen test (Neisseria meningitis A-C-
Y-W135 Ag, Streptococcus pneumoniae Ag) were nega-
tive; cultures for common pathogens and M. tuberculosis, 
quantitative polymerase chain reaction (PCR) to detect 
herpetic viruses (Herpes Simplex Virus-1, 2 and 6, Cyto-
megalovirus, Epstein Barr and Varicella Zoster Virus) 
were negative. The GeneXpert MTB/RIF assay (Cepheid) 
was also negative for CSF. In order to investigate other 
CNS diseases we performed the Link index [8] and oligo-
clonal band screen that resulted respectively normal and 
absent in CSF. Under a suspected diagnosis of clear liq-
uor meningitis, the patient was transferred to our ward. 
Patient’s past medical history revealed no referred con-
tacts with TB infected subjects. The screening test for 
human immunodeficiency virus and chest X-ray (CXR) 
were negative. Tuberculosis Skin Test (TST) was nega-
tive and QuantiferonTB-gold in peripheral whole blood 
(QuantiFERON-TB© Gold In Tube [(QFT-IT); Cellestis 
Limited Chadstone, Vic., Australia] was indeterminate.
In order to improve the diagnosis of TB, we performed 
an alternative immunological method based on multi-
functional T cells, which has been suggested in recent 
years as a new tool for the discrimination between active 
TB and latent TB infection (LTBI) [9]. In a previous study 
[10] we used an intracellular cytokine flow cytometry 
(ICCFC) protocol to asses mono-functional and multi-
functional Mtb-specific CD4+ in peripheral blood and 
we proposed an immune-based approach, which could 
improve the identification at single time point of sub-
jects with no TB infection or patients having active or 
latent TB. A receiver operating characteristic (ROC) 
analysis was performed to calculate optimal cut-off val-
ues for both activated CD4+ T cells and polyfunctional 
CD4+  T cells in order to discriminate infected (active 
TB and LTBI) from uninfected patients and active from 
latent stage. We performed a ROC analysis, and a cut-
off  >0.45% for activated CD4+  T cells was found as 
the value allowing the best combination of sensitivity 
(94.44%, 95% CI 72.2–99.8%) and specificity (100%, 95% 
Fig. 1 Brain magnetic resonance imaging (MRI). At the onset of the symptoms normal imaging was found (a), after 2 days leptomeningeal 
enhancement over the basilar cistern and hydrocephalus were relieved (b, c). At admission day 27, focal areas of signal restriction in correspond-
ence of the left caudate nucleus and of the posterior arm of the left internal capsule (d) were found suggesting a tuberculous cerebral vasculitis 
(TVC) as a complication
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CI 69.15–100%; AUC 0.9722; 95% CI 0.9141–1.030%, 
P < 0.0001) to differentiate Mtb-infected patients (active 
TB and LTBI) from healthy controls [10]. A further cut-
off  <0.182% for polyfunctional CD4+  T cells allowed 
the best combination of sensitivity (77.78%) and speci-
ficity (70%) to differentiate between active TB and LTBI 
subjects.
Although this study involved pulmonary TB, we tried to 
apply our algorithm to TB meningitis. The same method 
to stain peripheral blood was used to stain CSF. CSF 
(0.5 mL) was added to the 3 tubes of QFT-IT containing 
respectively, saline solution (negative control), phytohae-
magglutinin (positive control), and TB antigens (ESAT-
6, CFP-10, and TB 7.7). A costimulation with 5  μL/mL 
anti-CD28 plus anti-CD49d (BD Bioscience, Pharmin-
gen, Italy) and 10 μg/mL BrefeldinA (Sigma-Aldrich) was 
added in all tubes [10]. After 18 h of incubation, the cell 
surface staining was performed with the markers anti-
CD45-VioBlue and anti-CD4 PE-Vio770 (Miltenyi Bio-
tec, Germany), then the cells were lysed (BD Bioscience 
Lyse solution) and permeabilized (BD Bioscience Perm 
solution) and the intracellularly stained with anti-IFN-γ 
FITC, anti-TNF-α APC and anti-IL-2 PE (Miltenyi Bio-
tec). Eventually cells were acquired with a MACSQuant 
Analyzer flow cytometer (Miltenyi Biotec) and analysed 
with FlowJo Software version 10, that allowed us to per-
form a “combination gates” analysis. Seven different pop-
ulation cells were detected in CD4+ cell gate on the basis 
of IFN-γ, IL-2, and TNF-α produced by CD4+  (Addi-
tional file 1), as previously described [10].
The percentage of CD4+ T cells activated, defined 
as cells producing at least a cytokine, was elevated 
in peripheral whole blood (WB) (0.94%) and in CSF 
(2.86%) and using the cut-off (>0.45%) we scored the 
patient as a positive subject TB infected. Worthy of 
note, at this time the TST was negative, Quantiferon 
TB-gold was undetermined and a second PCR for M. 
tuberculosis in CSF was negative. Considering the poly-
functionality of T CD4+ cells, those simultaneously 
producing IFN-γ+  , IL-2+  and TNF-α+  in WB were 
0.01% and in CSF 0.40% of total CD4+ cells (Additional 
file  2). According to our cut-off (<0.182) the patient 
resulted as active TB in WB assay. Conversely in CSF 
a higher proportion of polyfunctional CD4+ (Fig.  2) 
was found comparable to the proportion registered in 
WB in LTBI patients. To date, few data are available 
regarding the measure of ICCFC at the site of TB infec-
tion, but it could be related to a high immunological 
response in the CSF, typical of TBM.
Moreover we carried out on the CSF extracted from 
the LP in the first day of hospitalization, the l ADA level 
which amounted to 18.31 UI/L, higher than the cut-off 10 
[11].
Two days later, due to persistent clinical symptoms and 
uncertainty in the tests of coordination, a second brain 
MRI was performed with a report of hypertensive hydro-
cephalus and a diffuse leptomeningeal enhancement of 
the basal cistern, in particular of the interpeduncular 
cistern, attributable to infectious-inflammatory altera-
tions. The brain MRI is shown in Fig. 1b, c. An encephalic 
drainage was inserted urgently.
Based on the clinical, radiological findings and CSF 
results (CD4+ polyfunctional response, ADA level, 
pleocytosis, hyperproteinorrachia and hypoglicor-
rachia) TBM was considered on admission day 3 and 
therapy was started with antituberculous drugs with iso-
niazid (H) 300  mg/day plus ethambutol (E) 500  mg/day 
plus rifampicin (R) 400  mg/day and pyrazinamide (Z) 
1000 mg/day, as well as intravenous steroids (dexametha-
sone 4 mg every 8 h).
Analysis of CSF obtained from LP and encephalic 
drainage in the following days revealed a different pro-
tein concentration, with higher level of protein in CSF 
extracted from LP compared to CSF extracted by ventric-
ular drain (Table 1).
Renal and liver function, bilirubin and uric acid levels 
were monitored regularly. Serial CSF values are shown in 
Table 1. On day 9 a “in house” nested PCR amplifying a 
123 base pair fragment of the M. tuberculosis DNA was 
performed using CSF with a positive result, while the The 
GeneXpert MTB/RIF assay was negative.
The family screening was performed and only the 
father was found TST positive with normal chest radiog-
raphy and chest CT scan.
Once the patient’s condition stabilized, the HERZ regi-
men was continued and dexamethasone was gradually 
decreased. However, on admission day 27, because of an 
acute onset of aphasia with right hemiplegia, an emer-
gency brain MRI was performed (Fig.  1d). The findings 
were compatible with tuberculous cerebral vasculitis 
(TVC), resulting in a diagnosis of ischemia with two focal 
areas of signal restriction in correspondence of the left 
caudate nucleus and of the posterior arm of the left inter-
nal capsule. We increased the corticosteroid dosage and 
treatment with enoxaparin and aspirin was added.
On admission day 74, there were no further episodes of 
fever, the neurological examination was normal with total 
disappearance of hemiplegia, the facial asymmetry and 
the double vision, thanks to neurological rehabilitation. 
The patient was discharged in good condition without 
significant neurological sequelae besides the presence of 
a slight disorder of attention and concentration and with 
recommendation to continue the treatment with HERZ 
regimen and aspirin. She was followed up at the outpa-
tient clinic and a follow-up MRI of brain is shown on the 
Fig. 1d. Child is on regular follow-up.
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Discussion and conclusions
We report a case of TBM complicated with hydrocepha-
lus and cerebral vasculitis tuberculosis (TVC), which 
benefited from early diagnosis, based on unconven-
tional methods, and an early TB treatment increasing the 
chance of a favourable outcome.
TBM remains the most lethal form of M. tubercu-
losis and a recent large childhood study documented 
neurological disability in about 75% of survivors, 
despite an exceptionally low mortality rate of only 
13% and a treatment with antituberculosis chemo-
therapy [12].
Early diagnosis and treatment of TBM is the single 
most important factor determining outcome [13–15]. 
Although prompt and rapid identification of TBM is cru-
cial for a successful disease management, in most cases, 
the diagnosis is significantly delayed with a consequent 
delay in the initiation of therapy, which is often attribut-
able to the use of slow or relatively insensitive conven-
tional diagnostic tests [16].
Fig. 2 Flowcytometric analysis of CD4+ T cells of blood and CSF after stimulation with TB antigens. The gating strategy excluded debris and identi-
fied CD4+ on CD45+ lymphocytes. The subsequent analysis was on CD4+ gate to describe IFN-γ, IL-2, and TNF-α total producing T cells. At the 
bottom the percentages of the different population cells, calculated by FlowJo Software version 7.6.5 were showed and were defined in CD4+ cell 
gate on the basis of total IFN-γ, IL-2, and TNF-α producing. T cells producing any of the 3 cytokines (IFN-γ or IL-2 or TNF-α) were defined as “activated 
T cells”
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The diagnosis of TBM is difficult because of unspecific 
symptoms and signs.
There are some evidences that a combination of clini-
cal and simple laboratory data might help in the diag-
nosis [17]. Certain clinical characteristics such as longer 
duration of symptoms (>6 days), moderate CSF pleocy-
tosis, and the presence of focal deficits increase the prob-
ability of TBM [17–19]. Characteristic CSF findings of 
TBM include lymphocytic-predominant pleocytosis, a 
total white cell count of 100–500 cells/μL, elevated pro-
tein levels (typically between 100 and 500  mg/dL) and 
low glucose, usually less than 45 mg/dL or CSF: plasma 
ratio  <0.5 [20]. Marais et  al. [19] have created a score 
based on clinical, CSF data and cerebral imaging crite-
ria plus evidence of TB elsewhere. According to these 
authors, probable TBM is defined by a score between 
10 and 12, whereas possible TBM is defined by a score 
higher than 6. At the admission to our ward the patient 
obtained a Marais score of 6 (4 scores for the CSF find-
ings and 2 scores for clinical criteria) that was insufficient 
to speculate a TBM diagnosis.
In our case report neither the microscopy, to detect 
acid-fast bacilli in the CSF, nor culture resulted positive 
since TBM is a paucibacillary form of tuberculosis so 
they were unhelpful in making diagnosis. The likelihood 
of seeing or culturing M. tuberculosis from the CSF is 
dependent upon meticulous microscopy and culture of a 
large volume (>5 mL) of CSF [21] that is difficult in most 
cases, especially in children. In fact microscopy, although 
rapid and inexpensive, has very low sensitivity (10–20%), 
while culture is too slow and insensitive (<50%) to aid 
clinical decision-making [17].
In the last decades nucleic acid-based amplification 
(NAA) tests have emerged as potentially important tools 
for diagnosing TBM, unfortunately they have a high 
specificity (97–99%) but low sensitivity (46–66%) [22]. 
In our patient the first molecular test used (GeneXpert 
MTB/RIF assay, Cepheid) was negative. Improving the 
conditions of the CSF sample pre-treatment prior to 
DNA extraction and increasing the sensitivity of molecu-
lar test using a nested PCR [23], it was possible to con-
firm the suspect of TBM in our patient.
To increase the chance to detect TB infection we used 
whole blood QFT-G-IT (an Interferon Gamma Release 
Assay, IGRA) to detect the response to stimuli with spe-
cific TB antigens. Our child obtained an IGRA on whole 
blood indeterminate, in accordance with Vidhate and col-
leagues [24] who found that whole blood QFT-G-IT had 
low sensitivity and specificity in diagnosing TBM and 
CSF QFT-G-IT was useful neither in diagnosis nor in 
predicting the outcome, due to indeterminate results.
We used unconventional diagnostic method to address 
the diagnosis. We measured the adenosine deaminase 
activity (ADA), an enzyme that is widely distributed in 
tissues and body fluids, that has been used in the diag-
nosis of pleural, meningeal and pericardial TB [25]. Vari-
ous studies have demonstrated that CSF-ADA estimation 
can differentiate TBM from normal subjects or other 
infectious meningitis [26, 27]. We measured ADA level 
by a spectrophotometric method described by Guisti 
and Galanti [28] and it resulted positive only in the first 
determination at day 1 (Fig.  3). Once we started the 
anti-TB treatment, it always resulted normal except on 
day 27 when the child had a TVC and the level slightly 
increased. ADA measurement on CSF has contributed to 
diagnosis although the cut-off level that defines a positive 
result has not been determined [7] limiting the use of this 
test.
Furthermore we performed an innovative assay to 
detect the CD4 intracellular response in whole blood 
Fig. 3 Trend of proteins, glucose and ADA levels in CSF at the different time points. The protein level was always high, while the glucose level was 
constantly low. The ADA level showed a slow decline after the beginning of therapy
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and CSF based on the premise that mononuclear cells 
localised to infected sites produce more cytokines than 
peripheral blood mononuclear cells (PBMC) [29], which 
has also been demonstrated in other tissues [30, 31]. 
Intracellular response in peripheral blood showed firstly 
a TB infection, revealed by neither TST nor Quantiferon. 
Moreover the polyfunctional CD4 profile suggested a 
pattern associated to active TB, according to the previ-
ously proposed algorithm [10]. The same test performed 
in CSF confirmed a M. tuberculosis infection with a high 
local immune specificity. In CSF the increased propor-
tion of CD4 cells producing cytokines (IL-2, INF-γ, TNF-
α) could reflect the high number of mononuclear cells 
localised to infected sites, typical of TBM. A similar phe-
nomenon was described in pleural [30] and alveolar fluid 
[31] in thoracic TB.
In our study the use of non conventional methods to 
detect TBM, such as intracellular staining of periph-
eral blood and of CSF followed by the detection of ADA 
activity and a in house nested PCR, helped us in the early 
diagnosis and treatment of TBM, despite the consecu-
tive negativity of classical diagnostic tests. A prospective 
study with a large number of children is needed to con-
firm this isolate observation.
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